Yipinhong Pharmaceutical Co Ltd banner

Yipinhong Pharmaceutical Co Ltd
SZSE:300723

Watchlist Manager
Yipinhong Pharmaceutical Co Ltd Logo
Yipinhong Pharmaceutical Co Ltd
SZSE:300723
Watchlist
Price: 32.82 CNY -2.15% Market Closed
Market Cap: ¥14.8B

Gross Margin

51.7%
Current
Declining
by 17.8%
vs 3-y average of 69.5%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
51.7%
=
Gross Profit
¥529.1m
/
Revenue
¥1B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
51.7%
=
Gross Profit
¥529.1m
/
Revenue
¥1B

Peer Comparison

Country Company Market Cap Gross
Margin
CN
Yipinhong Pharmaceutical Co Ltd
SZSE:300723
14.8B CNY
Loading...
US
Eli Lilly and Co
NYSE:LLY
969.6B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
588.3B USD
Loading...
CH
Roche Holding AG
SIX:ROG
293.6B CHF
Loading...
CH
Novartis AG
SIX:NOVN
250.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
239.2B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
301.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
154.1B USD
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
123.9B USD
Loading...

Market Distribution

Higher than 85% of companies in China
Percentile
85th
Based on 8 314 companies
85th percentile
51.7%
Low
-2 148% — 14.3%
Typical Range
14.3% — 34.6%
High
34.6% — 775.2%
Distribution Statistics
China
Min -2 148%
30th Percentile 14.3%
Median 23%
70th Percentile 34.6%
Max 775.2%

Yipinhong Pharmaceutical Co Ltd
Glance View

Market Cap
14.8B CNY
Industry
Pharmaceuticals

Yipinhong Pharmaceutical Co Ltd has carved its niche in the pharmaceutical landscape of China, with its roots embedded deeply in the nation's flourishing healthcare sector. Known for its dedication to combining traditional Chinese medicinal practices with modern scientific research, the company stands out in an increasingly competitive market. Yipinhong's operations are centered around developing, manufacturing, and distributing a broad spectrum of medicinal products that adhere to the highest quality standards. By focusing on therapeutic areas such as respiratory, cardiovascular, and gastrointestinal health, they strategically align with the growing demand for reliable medicinal solutions. What makes Yipinhong truly distinctive is its investment in research and development that drives innovation. This focus not only ensures a continuous pipeline of new products but positions them as a leader in the integration of traditional remedies with cutting-edge pharmaceutical science. The company thrives on a business model that maximizes its robust distribution network, encompassing both domestic and international markets. Yipinhong capitalizes on its vast network of sales agents and partnerships with hospitals, clinics, and pharmacies to ensure its products reach consumers efficiently. This network amplifies their revenue streams by tapping into various segments within the pharmaceutical supply chain. Moreover, Yipinhong's strategic collaborations for research and development and their participation in healthcare industry events bolster their market presence and brand recognition. By maintaining a harmonious balance between traditional approaches and modern demands, Yipinhong not only captures a unique market position but also sets a benchmark in pharmaceutical excellence and innovation.

Intrinsic Value
8.85 CNY
Overvaluation 73%
Intrinsic Value
Price
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
51.7%
=
Gross Profit
¥529.1m
/
Revenue
¥1B
What is Yipinhong Pharmaceutical Co Ltd's current Gross Margin?

The current Gross Margin for Yipinhong Pharmaceutical Co Ltd is 51.7%, which is below its 3-year median of 69.5%.

How has Gross Margin changed over time?

Over the last 3 years, Yipinhong Pharmaceutical Co Ltd’s Gross Margin has decreased from 85.8% to 51.7%. During this period, it reached a low of 49.1% on Jun 30, 2025 and a high of 86.8% on Dec 31, 2022.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett